Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel, Cisplatin, and Re-Irradiation for Recurrent Head and Neck Cancer
NCT00005087Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Mar 2000
- Primary completion
- Nov 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of paclitaxel, cisplatin in head and neck squamous cell carcinoma (HNSCC), sponsored by NRG Oncology. Started Mar 2000; status: completed.
02
Drugs
paclitaxelcisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00005087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005087.